
We describe a novel, potent zzso zzso zzso inhibitor of protein zzso B zzso The compound selectively kills prostate cancer cells, in which zzso is highly zzso but not normal cells, or cancer cells in which zzso is not zzso The inhibitor zzso zzso and zzso the zzso of zzso zzso in prostate cancer cell lines and significantly increases the efficacy of chemotherapy agents to induce prostate cancer cell death, when given in zzso In zzso the inhibitor exhibits a strong zzso effect in two prostate cancer mouse zzso Moreover, treated animals develop significantly less lung zzso compared to zzso ones, and the effect is accompanied by a significant decrease in blood zzso zzso zzso levels in treated zzso This compound and its potential zzso may be developed into novel, zzso and safe zzso agents, both as zzso treatment and in combination with other chemotherapy zzso 

